Novartis (NOTA) Q3 2024 Earnings Report
DE:NOTA Q3 2024 EPS Results
- Actual EPS
- EUR 1.85
- Consensus EPS
- EUR 1.74
- Beat/Miss
- Beat by +EUR 0.11
- One Year Ago EPS
- EUR 1.56
DE:NOTA Q3 2024 Revenue Results
- Actual Revenue
- EUR 11.65B
- Expected Revenue
- EUR 11.50B
- Beat/Miss
- Beat by +EUR 153.47M
- YoY Revenue Growth
- +10.52%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/29/2024
- Time
- Before Open
- Conference Call
- Tuesday, October 29, 2024
DE:NOTA Upcoming Earnings
Novartis's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
DE:NOTA Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NOTA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 2.01- | 1.82 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 2.042.21 | 2.02 | 9.33% (+0.19) | |
| Jul 21, 2026 | 2026 (Q2) | 1.952.17 | 2.18 | -0.41% (-0.01) | |
| Apr 28, 2026 | 2026 (Q1) | 1.891.79 | 2.05 | -12.72% (-0.26) | |
| Feb 04, 2026 | 2025 (Q4) | 1.781.82 | 1.78 | 2.53% (+0.04) | |
| Oct 28, 2025 | 2025 (Q3) | 2.042.02 | 1.85 | 9.22% (+0.17) | |
| Jul 17, 2025 | 2025 (Q2) | 2.112.18 | 1.77 | 22.84% (+0.40) | |
| Apr 29, 2025 | 2025 (Q1) | 1.902.05 | 1.62 | 26.67% (+0.43) | |
| Jan 31, 2025 | 2024 (Q4) | 1.621.78 | 1.38 | 29.41% (+0.40) | |
| Oct 29, 2024 | 2024 (Q3) | 1.741.85 | 1.56 | 18.39% (+0.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed